TrialPanorama/TrialPanorama-database huggingface dataset:
Study NCT05709535 — Predictive Biomarker (PRD): Glutamate carboxypeptidase II
Genes: FOLH1; FOLH; NAALAD1; PSM; PSMA; GIG27
Study NCT04912869 — Predictive Biomarker (PRD): SCD mRNA
Genes: SCD; FADS5; SCD1; SCDOS
Study NCT04912869 — Pharmacodynamic Biomarker (PDY): Complement C5
Genes: C5; CPAMD4
Study NCT06384976 — Predictive Biomarker (PRD): B-lymphocyte surface antigen B4
Genes: CD19
Study NCT06448468 — Predictive Biomarker (PRD); Safety Biomarker (SAF): DES mRNA
Genes: DES
Study NCT05675917 — Predictive Biomarker (PRD): AMD1 mRNA
Genes: AMD1; AMD
Study NCT05675917 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05700071 — Pharmacodynamic Biomarker (PDY): 2-hydroxyglutarate
Study NCT05525767 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT06323772 — Predictive Biomarker (PRD): PDE6B mRNA
Genes: PDE6B; PDEB
Study NCT04963764 — Monitoring Biomarker (MOI): Procalcitonin
Study NCT04603807 — Predictive Biomarker (PRD): ROS1 mRNA
Genes: ROS1; MCF3; ROS
Study NCT06063369 — Predictive Biomarker (PRD): PPARA mRNA
Genes: PPARA; NR1C1; PPAR
Study NCT06063369 — Safety Biomarker (SAF): Peroxisome proliferator-activated receptor alpha
Genes: PPARA
Study NCT06364631 — Safety Biomarker (SAF): PDCD1
Genes: CD279; PD1; hSLE1; PD-1
Study NCT06364631 — Predictive Biomarker (PRD): Programmed cell death 1 ligand 1
Genes: CD274; B7H1; PDCD1L1; PDCD1LG1; PDL1
Study NCT06364631 — Safety Biomarker (SAF): Cytotoxic T-lymphocyte protein 4
Genes: CTLA4; CD152
Study NCT06364631 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study NCT05183828 — Predictive Biomarker (PRD); Safety Biomarker (SAF): HSD3B1 mRNA
Genes: HSD3B1; 3BH; HSDB3A
Study NCT04686643 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05006378 — Pharmacodynamic Biomarker (PDY): Blood coagulation
Study NCT05312879 — Predictive Biomarker (PRD): APOL1 mRNA
Genes: APOL1; APOL
Study NCT06563895 — Predictive Biomarker (PRD): TTR mRNA
Genes: TTR; PALB
Study NCT06642545 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study NCT06642545 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT04206644 — Predictive Biomarker (PRD): JAK1 mRNA
Genes: JAK1; JAK1A; JAK1B
Study NCT05570903 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT04731103 — Predictive Biomarker (PRD): TREX1 mRNA
Genes: TREX1
Study NCT04731103 — Predictive Biomarker (PRD): RNASEH2A mRNA
Genes: RNASEH2A; RNASEHI; RNHIA
Study NCT04731103 — Predictive Biomarker (PRD): RNASEH2B mRNA
Genes: RNASEH2B; DLEU8
Study NCT04731103 — Predictive Biomarker (PRD): RNASEH2C mRNA
Genes: RNASEH2C; AYP1
Study NCT05570552 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06305598 — Predictive Biomarker (PRD): AR mRNA
Genes: AR; DHTR; NR3C4
Study NCT05097053 — Surrogate Endpoint (SUR): Neutralizing antibody
Study NCT04298606 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT04298606 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT04851444 — Predictive Biomarker (PRD): ACE2 mRNA
Genes: ACE2; UNQ868/PRO1885
Study NCT05173077 — Predictive Biomarker (PRD): MOXD1 mRNA
Genes: MOXD1; MOX; UNQ2493/PRO5780
Study NCT05013216 — Predictive Biomarker (PRD): KRAS mRNA
Genes: KRAS; KRAS2; RASK2
Study NCT06381635 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT06381635 — Safety Biomarker (SAF): Transforming growth factor beta 1
Genes: TGFB1; TGFB
Study NCT05550636 — Predictive Biomarker (PRD): CYP3A4 mRNA
Genes: CYP3A4; CYP3A3
Study NCT05526118 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT05445479 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT05711992 — Predictive Biomarker (PRD): FOXR2 mRNA
Genes: FOXR2; FOXN6
Study NCT05711992 — Predictive Biomarker (PRD): BCOR mRNA
Genes: BCOR; KIAA1575
Study NCT04658264 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05537051 — Predictive Biomarker (PRD): TIGIT mRNA
Genes: TIGIT; VSIG9; VSTM3
Study NCT04966455 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT04966455 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05452798 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study NCT05452798 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT05452798 — Predictive Biomarker (PRD): Hormone receptor
Study NCT05452798 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT06425705 — Pharmacodynamic Biomarker (PDY): Angiotensinogenase renin
Genes: REN
Study NCT05530083 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04642274 — Predictive Biomarker (PRD): ERAS mRNA
Genes: ERAS; HRAS2; HRASP
Study NCT05012072 — Predictive Biomarker (PRD): CRH mRNA
Genes: CRH
Study NCT04853017 — Predictive Biomarker (PRD): KRAS mRNA
Genes: KRAS; KRAS2; RASK2
Study NCT04853017 — Predictive Biomarker (PRD): NRAS mRNA
Genes: NRAS; HRAS1
Study NCT05641519 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05502601 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT05502601 — Surrogate Endpoint (SUR): Probing pocket depth
Study NCT04746924 — Predictive Biomarker (PRD): TIGIT mRNA
Genes: TIGIT; VSIG9; VSTM3
Study NCT04992234 — Predictive Biomarker (PRD): CFTR mRNA
Genes: CFTR; ABCC7
Study NCT05541432 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT05728736 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY): Microtubule-associated protein tau
Genes: MAPT; MAPTL; MTBT1; TAU
Study NCT06028789 — Predictive Biomarker (PRD): CTLA4
Genes: CD152; CD; GSE; CTLA-4
Study NCT06302374 — Surrogate Endpoint (SUR): Neutralizing antibody
Study NCT05983952 — Predictive Biomarker (PRD): CD38 mRNA
Genes: CD38
Study NCT05983952 — Predictive Biomarker (PRD): TPO mRNA
Genes: TPO
Study NCT05983952 — Surrogate Endpoint (SUR): Platelet count response
Study NCT06104774 — Surrogate Endpoint (SUR): Forced vital capacity
Study NCT04969757 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06131450 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT06781762 — Predictive Biomarker (PRD); Monitoring Biomarker (MOI): BDNF mRNA
Genes: BDNF
Study NCT06781762 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06781762 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT06781762 — Safety Biomarker (SAF): BDNF
Study NCT06779851 — Safety Biomarker (SAF): PDCD1
Genes: CD279; PD1; hSLE1; PD-1
Study NCT06779851 — Safety Biomarker (SAF): Interleukin 18
Genes: IL18; IGIF; IL1F4
Study NCT05865691 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): D-dimer
Study NCT06780865 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05863819 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT04647019 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT04647019 — Pharmacodynamic Biomarker (PDY): Superoxide dismutase Cu-Zn
Genes: SOD1
Study NCT04990817 — Predictive Biomarker (PRD): TG mRNA
Genes: TG
Study NCT04990817 — Pharmacodynamic Biomarker (PDY): High density lipoprotein cholesterol
Study NCT04990817 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06751381 — Predictive Biomarker (PRD): MYRF mRNA
Genes: MYRF; C11orf9; KIAA0954; MRF
Study NCT06765980 — Predictive Biomarker (PRD): AMD1 mRNA
Genes: AMD1; AMD
Study NCT05628246 — Predictive Biomarker (PRD): BPI mRNA
Genes: BPI
Study NCT06782334 — Predictive Biomarker (PRD): AMT mRNA
Genes: AMT; GCST
Study NCT06771960 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT05342636 — Safety Biomarker (SAF): PDCD1
Genes: CD279; PD1; hSLE1; PD-1
Study NCT05402345 — Predictive Biomarker (PRD): NGLY1 mRNA
Genes: NGLY1; PNG1
Study NCT06770296 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT06148506 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study NCT06148506 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT04294043 — Predictive Biomarker (PRD): NTM mRNA
Genes: NTM; IGLON2; NT; UNQ297/PRO337
Study NCT06433050 — Predictive Biomarker (PRD): SLC5A1 mRNA
Genes: SLC5A1; NAGT; SGLT1
Study NCT06433050 — Predictive Biomarker (PRD): SLC5A2 mRNA
Genes: SLC5A2; SGLT2
Study NCT05792436 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06346067 — Predictive Biomarker (PRD): NRAS mRNA
Genes: NRAS; HRAS1
Study NCT05818709 — Safety Biomarker (SAF): Hyaluronic acid
Study NCT06253507 — Predictive Biomarker (PRD): CD34 mRNA
Genes: CD34
Study NCT06116890 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT06116890 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study NCT05229822 — Predictive Biomarker (PRD): LBP mRNA
Genes: LBP
Study NCT05229822 — Predictive Biomarker (PRD): CD14 mRNA
Genes: CD14
Study NCT06227325 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT05633979 — Predictive Biomarker (PRD): EZH2
Genes: EZH1; ENX-1; KMT6; KMT6A
Study NCT05633979 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT05471843 — Predictive Biomarker (PRD): Apoptosis regulator Bcl-2
Genes: BCL2
Study NCT05083364 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Complement C3
Genes: C3; CPAMD1
Study NCT06572384 — Surrogate Endpoint (SUR): Forced vital capacity
Study NCT06574555 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05318157 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Immunoglobulin E
Study NCT05312697 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT04920708 — Predictive Biomarker (PRD): CDK4 mRNA
Genes: CDK4
Study NCT04920708 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT04920708 — Predictive Biomarker (PRD): Hormone receptor
Study NCT04920708 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT06621602 — Pharmacodynamic Biomarker (PDY): Synuclein alpha
Genes: SNCA; NACP; PARK1
Study NCT06774729 — Predictive Biomarker (PRD): STS mRNA
Genes: STS; ARSC1
Study NCT00019890 — Predictive Biomarker (PRD): CD34 mRNA
Genes: CD34
Study NCT05724524 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05556603 — Monitoring Biomarker (MOI): Circulating tumor DNA
Study NCT06430437 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT06377657 — Predictive Biomarker (PRD): METRNL mRNA
Genes: METRNL
Study NCT05242432 — Surrogate Endpoint (SUR): Neutralizing antibody
Study NCT04869787 — Predictive Biomarker (PRD): SCD mRNA
Genes: SCD; FADS5; SCD1; SCDOS
Study NCT05941481 — Safety Biomarker (SAF): PDCD1
Genes: CD279; PD1; hSLE1; PD-1
Study NCT05974826 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04784416 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY): Microtubule-associated protein tau
Genes: MAPT; MAPTL; MTBT1; TAU
Study NCT04751669 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT04751669 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Monitoring Biomarker (MOI): Vitamin B12
Study NCT04542603 — Predictive Biomarker (PRD): TSPO mRNA
Genes: TSPO; BZRP; MBR
Study NCT06149130 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study NCT06149130 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT06149130 — Predictive Biomarker (PRD): CDK4 mRNA
Genes: CDK4
Study NCT06693830 — Monitoring Biomarker (MOI): Circulating tumor DNA
Study NCT05324150 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT05324150 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study NCT05757245 — Predictive Biomarker (PRD): CD34 mRNA
Genes: CD34
Study NCT06349538 — Pharmacodynamic Biomarker (PDY): Synuclein alpha
Genes: SNCA; NACP; PARK1
Study NCT05812781 — Predictive Biomarker (PRD): CAPS mRNA
Genes: CAPS
Study NCT05207709 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT05207709 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study NCT05207709 — Predictive Biomarker (PRD): CDK4 mRNA
Genes: CDK4
Study NCT05207709 — Predictive Biomarker (PRD): Hormone receptor
Study NCT06734884 — Predictive Biomarker (PRD): Interleukin 5
Genes: IL5
Study NCT05087524 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT06774534 — Predictive Biomarker (PRD): SERPINB3 mRNA
Genes: SERPINB3; SCCA; SCCA1
Study NCT04816838 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT04816838 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT06771427 — Predictive Biomarker (PRD); Safety Biomarker (SAF): DES mRNA
Genes: DES
Study NCT04891744 — Predictive Biomarker (PRD): TNFRSF17 mRNA
Genes: TNFRSF17; BCM; BCMA
Study NCT06779539 — Predictive Biomarker (PRD): ALK tyrosine kinase receptor
Genes: ALK
Study NCT06773026 — Predictive Biomarker (PRD): ACADM mRNA
Genes: ACADM
Study NCT05986487 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05309122 — Surrogate Endpoint (SUR): Cervical intraepithelial neoplasia
Study NCT06508346 — Predictive Biomarker (PRD): B-lymphocyte surface antigen B4
Genes: CD19
Study NCT05718245 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06332196 — Predictive Biomarker (PRD): RTEL1 mRNA
Genes: RTEL1; C20orf41; KIAA1088; NHL
Study NCT06782009 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06782009 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT05275985 — Predictive Biomarker (PRD): FAP mRNA
Genes: FAP
Study NCT04764214 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT05720884 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05049226 — Surrogate Endpoint (SUR): Neutralizing antibody
Study NCT05297630 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): Neutrophil gelatinase-associated lipocalin
Genes: LCN2; HNL; NGAL
Study NCT05880056 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05935280 — Predictive Biomarker (PRD): TRPM8 mRNA
Genes: TRPM8; LTRPC6; TRPP8
Study NCT05935280 — Predictive Biomarker (PRD): TRPA1 mRNA
Genes: TRPA1; ANKTM1
Study NCT05174650 — Predictive Biomarker (PRD): FGFR2 mRNA
Genes: FGFR2; BEK; KGFR; KSAM
Study NCT04709302 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT04709302 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): D-dimer
Study NCT04776525 — Predictive Biomarker (PRD): STS mRNA
Genes: STS; ARSC1
Study NCT04776525 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Cellular tumor antigen p53
Genes: TP53; P53
Study NCT05397093 — Predictive Biomarker (PRD): Folate receptor alpha
Genes: FOLR1; FOLR
Study NCT06197672 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT05276050 — Predictive Biomarker (PRD): Coagulation factor VIII
Genes: F8; F8C
Study NCT05811689 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT05197322 — Predictive Biomarker (PRD): Microsatellite instability
Study NCT04784520 — Predictive Biomarker (PRD): BTC mRNA
Genes: BTC
Study NCT04720664 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT04720664 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study NCT04720664 — Predictive Biomarker (PRD): Hormone receptor
Study NCT03186456 — Predictive Biomarker (PRD): MSC mRNA
Genes: MSC; ABF1; BHLHA22
Study NCT05760729 — Predictive Biomarker (PRD); Monitoring Biomarker (MOI): BDNF mRNA
Genes: BDNF
Study NCT05760729 — Safety Biomarker (SAF): BDNF
Study NCT05062629 — Predictive Biomarker (PRD): ALPL mRNA
Genes: ALPL
Study NCT06440694 — Predictive Biomarker (PRD): PTS mRNA
Genes: PTS
Study NCT04769622 — Surrogate Endpoint (SUR): Probing pocket depth
Study NCT05585047 — Predictive Biomarker (PRD): GAD1 mRNA
Genes: GAD1; GAD; GAD67
Study NCT05644743 — Predictive Biomarker (PRD): Vitamin D-binding protein
Genes: GC
Study NCT05666700 — Predictive Biomarker (PRD): TNFRSF17 mRNA
Genes: TNFRSF17; BCM; BCMA
Study NCT06055959 — Pharmacodynamic Biomarker (PDY): Antidrug antibody
Study NCT05652543 — Surrogate Endpoint (SUR): Neutralizing antibody
Study NCT06326762 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT06326762 — Predictive Biomarker (PRD); Safety Biomarker (SAF): White blood cell
Study NCT04088422 — Monitoring Biomarker (MOI): Cell-free DNA
Study NCT05165823 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06464679 — Predictive Biomarker (PRD): B-lymphocyte surface antigen B4
Genes: CD19
Study NCT05420987 — Predictive Biomarker (PRD): ACE2 mRNA
Genes: ACE2; UNQ868/PRO1885
Study NCT05420987 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05136183 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study NCT05136183 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Interleukin 8
Genes: CXCL8; IL8
Study NCT06363435 — Predictive Biomarker (PRD): Glutamate carboxypeptidase II
Genes: FOLH1; FOLH; NAALAD1; PSM; PSMA; GIG27
Study NCT06558877 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05863962 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05655481 — Predictive Biomarker (PRD): PAH mRNA
Genes: PAH
Study NCT03872505 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT03872505 — Surrogate Endpoint (SUR): Pathological complete response
Study NCT06561022 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study NCT06561022 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT06478875 — Predictive Biomarker (PRD): CXCR4 mRNA
Genes: CXCR4
Study NCT04326751 — Monitoring Biomarker (MOI): Circulating tumor DNA
Study NCT00000697 — Predictive Biomarker (PRD); Safety Biomarker (SAF): White blood cell
Study NCT05184959 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06007937 — Predictive Biomarker (PRD): ALK tyrosine kinase receptor
Genes: ALK
Study NCT06310811 — Predictive Biomarker (PRD): B-lymphocyte surface antigen B4
Genes: CD19
Study NCT04865952 — Safety Biomarker (SAF): Hyaluronic acid
Study NCT05986357 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT05016063 — Predictive Biomarker (PRD): Myeloid cell surface antigen CD33
Genes: CD33; SIGLEC3
Study NCT04463615 — Predictive Biomarker (PRD): Lymphocyte activation antigen CD30
Genes: TNFRSF8; CD30; D1S166E
Study NCT04763746 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05318066 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06425978 — Safety Biomarker (SAF): Hyaluronic acid
Study NCT05212766 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT04666311 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT04666311 — Predictive Biomarker (PRD); Safety Biomarker (SAF): White blood cell
Study NCT05153850 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT05153850 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT05782647 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06002230 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT04962893 — Surrogate Endpoint (SUR): Neutralizing antibody response
Study NCT04962893 — Surrogate Endpoint (SUR): Neutralizing antibody
Study NCT06234137 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT05380024 — Predictive Biomarker (PRD): ALK tyrosine kinase receptor
Genes: ALK
Study NCT04704505 — Predictive Biomarker (PRD): RRAD mRNA
Genes: RRAD; RAD
Study NCT04704505 — Predictive Biomarker (PRD): GNRH1 mRNA
Genes: GNRH1; GNRH; GRH; LHRH
Study NCT05207280 — Predictive Biomarker (PRD): Arginine vasopressin
Genes: AVP; ARVP; VP
Study NCT06085807 — Predictive Biomarker (PRD): PRKD1 mRNA
Genes: PRKD1; PKD; PKD1; PRKCM
Study NCT05969002 — Predictive Biomarker (PRD): EMD mRNA
Genes: EMD; EDMD; STA
Study NCT05294471 — Predictive Biomarker (PRD): Liver iron
Study NCT05382377 — Predictive Biomarker (PRD): KLRK1 mRNA
Genes: KLRK1; D12S2489E; NKG2D
Study NCT05063786 — Predictive Biomarker (PRD): PIK3CA mRNA
Genes: PIK3CA
Study NCT05063786 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT05003895 — Predictive Biomarker (PRD): GPC3 mRNA
Genes: GPC3; OCI5
Study NCT05256823 — Monitoring Biomarker (MOI): HBV DNA
Study NCT05451069 — Predictive Biomarker (PRD); Monitoring Biomarker (MOI): Chitinase-3-like protein 1
Genes: CHI3L1
Study NCT05451069 — Predictive Biomarker (PRD): CCR7 mRNA
Genes: CCR7; CMKBR7; EBI1; EVI1
Study NCT05451069 — Predictive Biomarker (PRD): Programmed cell death 1 ligand 1
Genes: CD274; B7H1; PDCD1L1; PDCD1LG1; PDL1
Study NCT05332496 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT05743595 — Predictive Biomarker (PRD): O-6-methylguanine-DNA-alkyltransferase
Genes: MGMT
Study NCT04518280 — Surrogate Endpoint (SUR): Pathological complete response
Study NCT04797195 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04877080 — Predictive Biomarker (PRD): B-lymphocyte surface antigen B4
Genes: CD19
Study NCT05822297 — Predictive Biomarker (PRD); Monitoring Biomarker (MOI): BDNF mRNA
Genes: BDNF
Study NCT05822297 — Safety Biomarker (SAF): BDNF
Study NCT06200220 — Predictive Biomarker (PRD): Apoptosis regulator Bcl-2
Genes: BCL2
Study NCT06232109 — Safety Biomarker (SAF): Cytochrome P450 2C19
Genes: CYP2C19
Study NCT06232109 — Predictive Biomarker (PRD): CYP3A4 mRNA
Genes: CYP3A4; CYP3A3
Study NCT06232109 — Safety Biomarker (SAF): Cytochrome P450 2D6
Genes: CYP2D6; CYP2DL1
Study NCT05608447 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04844489 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT04844489 — Surrogate Endpoint (SUR): Neutralizing antibody
Study NCT06354010 — Predictive Biomarker (PRD): GJB2 mRNA
Genes: GJB2
Study NCT05994937 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT05994937 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study NCT05994937 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2